Gamma Biosciences Makes Strategic Investment in Process Analytics and Continuous Bioprocessing Company, Nirrin Technologies

MENLO PARK, Calif. and BILLERICA, Mass.: MENLO PARK, Calif. and BILLERICA, Mass., Sept. 23, 2021 /PRNewswire/ -- Gamma Biosciences, a global life sciences company serving the advanced therapy market, today announced a strategic investment in Nirrin Technologies, a provider of next generation sensors and analytics for real-time, in-process monitoring and...

Click to view original post